Palette Life Sciences Receives Favorable Post Approval Study Results for Solesta® - March 29, 2022

read more

Palette Life Sciences Enters Into an Agreement with Lantheus to Support the Promotion of PYLARIFY® (Piflufolastat F 18) - February 24, 2022

read more

Palette Life Sciences Announces the Establishment of a Wholly Owned Subsidiary in Japan - February 15, 2022

read more

Palette Life Sciences Celebrates Twenty Years of Deflux Treatment for Vesicoureteral Reflux (VUR) in the United States - November 9, 2021

read more

Palette Life Sciences Secures Loan Facility for Up to $40 Million with Silicon Valley Bank - October 28, 2021

read more

Palette Life Sciences Announces Completion of $30 Million Equity Financing and Expansion of the Board of Directors - October 21, 2021

read more

Palette Life Sciences Launches Newly Branded Website Featuring United States Portfolio - September 16, 2021

read more

Palette Life Sciences Introduces Second Season of The PedSpace Podcast - March 23, 2021

read more

Palette Life Sciences Addresses Education and Training Needs of Pediatric Urologists through Expansive Global Digital Education Program - January 19, 2021

read more

Palette Life Sciences expands availability of online education and resources for paediatric urologists across Europe - October 27, 2020

read more